Disease measurement – enthesitis, skin, nails, spine and dactylitis

Wallace, 1951, The exposure treatment of burns, Lancet, 1, 501, 10.1016/S0140-6736(51)91975-7 Long, 1991, The finger-tip unit–a new practical measure, Clinical and Experimental Dermatology, 16, 444, 10.1111/j.1365-2230.1991.tb01232.x Long, 1992, The rule of hand: 4 hand areas=2 ftu=1 g, Archives of Dermatology, 128, 1129, 10.1001/archderm.1992.01680180125022 Fredriksson, 1978, Severe psoriasis–oral therapy with a new retinoid, Dermatologica, 157, 238, 10.1159/000250839 Ormerod, 1997, A comparison of subjective and objective measures of reduction of psoriasis with the use of ultrasound, reflectance colorimetry, computerized video image analysis, and nitric oxide production, Journal of the American Academy of Dermatology, 37, 51, 10.1016/S0190-9622(97)70211-1 Baughman, 1970, Psoriasis. A measure of severity, Archives of Dermatology, 101, 390, 10.1001/archderm.1970.04000040012004 Jacobson, 2004, Rethinking the psoriasis area and severity index: the impact of area should be increased, The British Journal of Dermatology, 151, 381, 10.1111/j.1365-2133.2004.06035.x Feldman, 1996, The self-administered psoriasis area and severity index is valid and reliable, The Journal of Investigative Dermatology, 106, 183, 10.1111/1523-1747.ep12329912 Henseler, 2008, A comparison between bsa, pasi, plasi and sapasi as measures of disease severity and improvement by therapy in patients with psoriasis, International Journal of Dermatology, 47, 1019, 10.1111/j.1365-4632.2008.03753.x Langley, 2004, Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician’s global assessment, Journal of the American Academy of Dermatology, 51, 563, 10.1016/j.jaad.2004.04.012 Berth-Jones, 2008, A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen psoriasis severity index, The British Journal of Dermatology, 159, 407, 10.1111/j.1365-2133.2008.08680.x Krueger, 1999, New method being developed for assessing psoriasis, National Psoriasis Foundation Forum, 5, 4 Carlin, 2003, Efficacy of acitretin and commercial tanning bed therapy for psoriasis, Archives of Dermatology, 139, 436, 10.1001/archderm.139.4.436 Farber, 1992, Nail psoriasis, Cutis; Cutaneous Medicine for the Practitioner, 50, 174 Elkayam, 2000, Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution, Clinical Rheumatology, 19, 301, 10.1007/PL00011173 Williamson, 2004, Extended report: nail disease in psoriatic arthritis–clinically important, potentially treatable and often overlooked, Rheumatology (Oxford), 43, 790, 10.1093/rheumatology/keh198 Jones, 1994, Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease, British Journal of Rheumatology, 33, 834, 10.1093/rheumatology/33.9.834 Rich, 2003, Nail psoriasis severity index: A useful tool for evaluation of nail psoriasis, Journal of the American Academy of Dermatology, 49, 206, 10.1067/S0190-9622(03)00910-1 Aktan, 2007, Interobserver reliability of the nail psoriasis severity index, Clinical and Experimental Dermatology, 32, 141, 10.1111/j.1365-2230.2006.02305.x Cassell, 2007, The modified nail psoriasis severity index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis, The Journal of Rheumatology, 34, 123 Mander, 1987, Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis, Annals of the Rheumatic Diseases, 46, 197, 10.1136/ard.46.3.197 Heuft-Dorenbosch, 2003, Assessment of enthesitis in ankylosing spondylitis, Annals of the Rheumatic Diseases, 62, 127, 10.1136/ard.62.2.127 Gorman, 2002, Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha, The New England Journal of Medicine, 346, 1349, 10.1056/NEJMoa012664 Braun, 2002, Treatment of active ankylosing spondylitis with infliximab: A randomised controlled multicentre trial, Lancet, 359, 1187, 10.1016/S0140-6736(02)08215-6 Marzo-Ortega, 2001, Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: A clinical and magnetic resonance imaging study, Arthritis and Rheumatism, 44, 2112, 10.1002/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H D’Agostino, 2003, Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study, Arthritis and Rheumatism, 48, 523, 10.1002/art.10812 McQueen, 2007, High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone, Annals of the Rheumatic Diseases, 66, 1581, 10.1136/ard.2007.070326 Maksymowych, 2009, Development and validation of the spondyloarthritis research consortium of Canada (sparcc) enthesitis index, Annals of the Rheumatic Diseases, 68, 948, 10.1136/ard.2007.084244 Healy, 2008, Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis, Arthritis and Rheumatism, 59, 686, 10.1002/art.23568 Gladman, 2007, International spondyloarthritis interobserver reliability exercise–the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis, The Journal of Rheumatology, 34, 1740 Rudwaleit, 2009, The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part ii): validation and final selection, Annals of the Rheumatic Diseases, 68, 777, 10.1136/ard.2009.108233 Taylor, 2006, Classification criteria for psoriatic arthritis: development of new criteria from a large international study, Arthritis and Rheumatism, 54, 2665, 10.1002/art.21972 Olivieri, 1996, Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging, Arthritis and Rheumatism, 39, 1524, 10.1002/art.1780390912 Gladman, 2004, The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada, The Journal of Rheumatology, 31, 1126 Helliwell, 2005, Development of an assessment tool for dactylitis in patients with psoriatic arthritis, The Journal of Rheumatology, 32, 1745 Healy, 2007, Measuring dactylitis in clinical trials: which is the best instrument to use?, The Journal of Rheumatology, 34, 1302 Healy, 2008, MRI changes in psoriatic dactylitis–extent of pathology, relationship to tenderness and correlation with clinical indices, Rheumatology (Oxford), 47, 92, 10.1093/rheumatology/kem315 Garrett, 1994, A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index, The Journal of Rheumatology, 21, 2286 Calin, 1994, A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index, The Journal of Rheumatology, 21, 2281 Jenkinson, 1994, Defining spinal mobility in ankylosing spondylitis (as). The bath as metrology index, The Journal of Rheumatology, 21, 1694 Chandran, 2007, Relationship between spinal mobility and radiographic damage in ankylosing spondylitis and psoriatic spondylitis: a comparative analysis, The Journal of Rheumatology, 34, 2463 Anderson, 2001, Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis, Arthritis and Rheumatism, 44, 1876, 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F Brandt, 2004, Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis, Annals of the Rheumatic Diseases, 63, 1438, 10.1136/ard.2003.016717 Lukas, 2009, Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis, Annals of the Rheumatic Diseases, 68, 18, 10.1136/ard.2008.094870 van der Heijde, 2008, The ASDAS is a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis, Annals of the Rheumatic Diseases Pedersen, 2009, Responsiveness of the ankylosing spondylitis disease activity score (ASDAS), and clinical and magnetic resonance imaging measures of disease activity in a 1 year follow-up study of patients with axial spondyloarthritis treated with TNF-{alpha} inhibitors, Annals of the Rheumatic Diseases Taylor, 2004, Could the bath ankylosing spondylitis disease activity index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?, Arthritis and Rheumatism, 51, 311, 10.1002/art.20421 Leung, 2008, Comparison of 4 functional indexes in psoriatic arthritis with axial or peripheral disease subgroups using rasch analyses, The Journal of Rheumatology, 35, 1613 Gladman, 2007, International spondyloarthritis interobserver reliability exercise–the inspire study: I. Assessment of spinal measures, The Journal of Rheumatology, 34, 1733